Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
ERK2 Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody
Supplier: Novus Biologicals NBP119102
Description
ERK2 Polyclonal specifically detects ERK2 in Human, Mouse samples. It is validated for Western Blot, Immunohistochemistry, Immunoprecipitation, Immunohistochemistry-Paraffin.Specifications
ERK2 | |
Polyclonal | |
Unconjugated | |
Tris-Citrate/Phosphate (pH 7.0 - 8.0) with 0.09% Sodium Azide | |
EC 2.7.11, EC 2.7.11.24, ERK, ERK-2, ERK2MAP kinase isoform p42, ERT1, Extracellular signal-regulated kinase 2, MAP kinase 1, MAP kinase 2, MAPK 1, MAPK2, mitogen-activated protein kinase 1, Mitogen-activated protein kinase 2, p38, p40, p41, p41mapk, p42-MAPK, P42MAPK, PRKM1MAPK 2, PRKM2, protein tyrosine kinase ERK2 | |
Rabbit | |
Affinity Purified | |
RUO | |
Primary | |
Based on 100% sequence identity, this antibody is predicted to react with Panda, Orangutan, Rhesus Monkey, Gorilla, Chimpanzee,Tasmanian devil, White-tufted-ear marmoset, Crab-eating macaque and Northern white-cheeked gibbon. | |
Store at 4C. Do not freeze. |
Western Blot, Immunohistochemistry, Immunoprecipitation, Immunohistochemistry (Paraffin) | |
1.0 mg/mL | |
Western Blot 1:2000-1:10000, Immunohistochemistry, Immunoprecipitation, Immunohistochemistry-Paraffin 1:10-1:500 | |
NP_002736.3 | |
MAPK1 | |
The immunogen recognized by this antibody maps to a region between residue 310 and 360 of human extracellular signal-regulated kinase-2 (mitogen-activated protein kinase 1) using the numbering given in entry NP_002736.3 (GeneID 5594). | |
100 μL | |
Angiogenesis, Apoptosis, Breast Cancer, Cancer, Diabetes Research, Hypoxia, Signal Transduction, Tumor Suppressors | |
5594 | |
Human, Mouse | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction